Distinct roles for IL-1 receptor type I signaling in early versus established Leishmania major infections

Journal of Investigative Dermatology

Volumn 126, Issue 7, 2006, Pages 1582-1589

  Kostka, Susanna Lopez ^a   Knop, Jürgen ^a   Konur, Abdo ^a   Udey, Mark C ^b   Von Stebut, Esther ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR TYPE 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 4; INTERLEUKIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; EX VIVO STUDY; FUNCTIONAL PROTEOMICS; IMMUNOCHEMISTRY; IMMUNOPATHOGENESIS; KNOCKOUT MOUSE; LEISHMANIA MAJOR; LEISHMANIASIS; MOUSE; NONHUMAN; PARASITE VIRULENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR INTRINSIC ACTIVITY; SIGNAL TRANSDUCTION; TH1 CELL; TH2 CELL;

ANIMALS; ANTIGENS, CD4; DISEASE PROGRESSION; GENE EXPRESSION REGULATION; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-4; L-SELECTIN; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, INTERLEUKIN-1; RECEPTORS, INTERLEUKIN-1 TYPE I; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, HELPER-INDUCER; TH1 CELLS; TH2 CELLS;

EID: 33745195004     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700309     Document Type: Article

References (40)

1. Ajdary S, Hosseini MH, Alimohammadian MH (1997) Recombinant interleukin-1 promotes leishmaniasis in susceptible mice. Microbiol Immunol 41:281-3
2. Belkaid Y, Mendez S, Lira R, Kadambi N, Milon G, Sacks D (2000) A natural model of Leishmania major infection reveals a prolonged "silent" phase of parasite amplification in the skin before the onset of lesion formation and immunity. J Immunol 165:969-77
3. Bersudsky M, Apte RN, El-On J (2000) Interleukin 1alpha activity of peritoneal and bone marrow macrophages infected with Leishmania major and Leishmania donovani in vitro. Exp Parasitol 94:150-7
4. Chakkalath HR, Titus RG (1994) Leishmania major-parasitized macrophages augment Th2-type T cell activation. J Immunol 153:4378-87
5. Cillari E, Dieli M, Maltese E, Milano S, Salerno A, Liew FY (1989) Enhancement of macrophage IL-1 production by Leishmania major infection in vitro and its inhibition by IFN-gamma. J Immunol 143:2001-5
6. Cumberbatch M, Dearman RJ, Groves RW, Antonopoulos C, Kimber I (2002) Differential regulation of epidermal Langerhans cell migration by interleukins (IL)-1alpha and IL-1beta during irritant- and allergen-induced cutaneous immune responses. Toxicol Appl Pharmacol 182:126-35
7. Curry AJ, Kaye PM (1992) Recombinant interleukin-1 alpha augments granuloma formation and cytokine production but not parasite clearance in mice infected with Leishmania donovani. Infect Immun 60:422-6
8. Delfino D, Chiofalo MS, Riggio G, Angelici MC, Gramiccia M, Gradoni L et al. (1995) Induction of interleukin 1 alpha in murine macrophages infected in vitro with different species and strains of Leishmania. Microb Pathog 18:73-80
9. Dinarello CA (1996) Biologic basis for interleukin-1 in disease. Blood 87:2095-147
10. + T cell polarization in mice is modulated by strain-specific major histocompatibility complex-independent differences within dendritic cells. J Exp Med 198:201-9
11. Germann T, Partenheimer A, Rude E (1990) Requirements for the growth of TH1 lymphocyte clones. Eur J Immunol 20:2035-40
12. Glaccum MB, Stocking KL, Charrier K, Smith JL, Willis CR, Makiszewski C et al. (1997) Phenotypic and functional characterization of mice that lack the type I receptor for IL-1. J Immunol 159:3364-71
13. + T cells. Differential effects of IL-1 on helper and inflammatory T cells. J Immunol 140:1555-60
14. Helmby H, Grencis RK (2004) Interleukin 1 plays a major role in the development of Th2-mediated immunity. Eur J Immunol 34:3674-81
15. Huber M, Beuscher HU, Rohwer P, Kurrle R, Rollinghoff M, Lohoff M (1998) Costimulation via TCR and IL-1 receptor reveals a novel IL-1alpha-mediated autocrine pathway of Th2 cell proliferation. J Immunol 160:4242-7
16. Hunter CA, Chizzonite R, Remington JS (1995) IL-1 beta is required for IL-12 to induce production of IFN-gamma by NK cells. A role for IL-1 beta in the T cell-independent mechanism of resistance against intracellular pathogens. J Immunol 155:4347-54
17. + T cell activation in vivo: with help from interleukin 1. J Exp Med 198:185-90
18. Jakob T, Udey MC (1998) Regulation of E-cadherin-mediated adhesion in Langerhans cell-like dendritic cells by inflammatory mediators that mobilize Langerhans cells in vivo. J Immunol 160:4067-73
19. Juffermans NP, Florquin S, Camoglio L, Verbon A, Kold AH, Speelman P et al. (2000) Interleukin-1 signaling is essential for host defence during murine pulmonary tuberculosis. J Infect Dis 182:902-8
20. Labow M, Shuster D, Zetterstrom M, Nunes P, Terry R, Cullinan EB et al. (1997) Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice. J Immunol 159:2452-61
21. Lacey DL, Erdmann JM (1990) IL-1 and IL-4 modulate IL-1 receptor expression in a murine T cell line. J Immunol 145:4145-53
22. Lichtman AH, Chin J, Schmidt JA, Abbas AK (1988) Role of interleukin 1 in the activation of T lymphocytes. Proc Natl Acad Sci USA 85:9699-703
23. Monteforte GM, Takeda K, Rodriguez-Sosa M, Akira S, David JR, Satoskar AR (2000) Genetically resistant mice lacking IL-18 gene develop Th1 response and control cutaneous Leishmania major infection. J Immunol 164:5890-3
24. Muraille E, De Trez C, Brait M, De Baetselier P, Leo O, Carlier Y (2003) Genetically resistant mice lacking MyD88-adapter protein display a high susceptibility to Leishmania major infection associated with a polarized Th2 response. J Immunol 170:4237-41
25. Pond L, Wassom DL, Hayes CE (1992) Influence of resistant and susceptible genotype, IL-1, and lymphoid organ on Trichinella spiralis-induced cytokine secretion. J Immunol 149:957-65
26. Reiner SL, Locksley RM (1995) The regulation of immunity to Leishmania major. Annu Rev Immunol 13:151-77
27. Sacks DL, Noben-Trauth N (2002) The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol 2:845-58
28. Satoskar AR, Okano M, Connaughton S, Raisanen-Sokolwski A, David JR, Labow M (1998) Enhanced Th2-like responses in IL-1 type 1 receptor-deficient mice. Eur J Immunol 28:2066-74
29. Schmitz N, Kurrer M, Kopf M (2003) The IL-1 receptor 1 is critical for Th2 cell type airway immune responses in a mild but not in a more severe asthma model. Eur J Immunol 33:991-1000
30. + T cells. Annu Rev Immunol 12:635-73
31. Shibuya K, Robinson D, Zonin F, Hartley SB, Macatonia SE, Somoza C et al. (1998) IL-1 alpha and TNF-alpha are required for IL-12-induced development of Th1 cells producing high levels of IFN-gamma in BALB/c but not C57BL/6 mice. J Immunol 160:1708-16
32. Sims JE, Dower SK (1994) Interleukin-1 receptors. Eur Cytokine Netw 5:539-46
33. Sims JE, Nicklin MJ, Bazan JF, Barton JL, Busfield SJ, Ford JE et al. (2001) A new nomenclature for IL-1-family genes. Trends Immunol 22:536-7
34. Soares MB, David JR, Titus RG (1997) An in vitro model for infection with Leishmania major that mimics the immune response in mice. Infect Immun 65:2837-45
35. Solari R, Smithers N, Page K, Bolton E, Champion BR (1990) Interleukin 1 responsiveness and receptor expression by murine TH1 and TH2 clones. Cytokine 2:129-41
36. von Stebut E, Belkaid Y, Nguyen BV, Cushing M, Sacks DL, Udey MC (2000) Leishmania major-infected murine Langerhans cell-like dendritic cells from susceptible mice release IL-12 after infection and vaccinate against experimental cutaneous Leishmaniasis. Eur J Immunol 30:3498-506
37. von Stebut E, Ehrchen JM, Belkaid Y, Kostka SL, Molle K, Knop J et al. (2003) Interleukin 1 alpha promotes Th1 differentiation and inhibits disease progression in Leishmania major-susceptible BALB/c mice. J Exp Med 198:191-9
38. Subramaniam S, Stansberg C, Cunningham C (2004) The interleukin 1 receptor family. Dev Comp Immunol 28:415-28
39. Theodos CM, Shankar A, Glasebrook AL, Roeder WD, Titus RC (1994) The effect of treating with anti-interleukin-1 receptor antibody on the course of experimental murine cutaneous leishmaniasis. Parasite Immunol 16:571-7
40. Wagner HM, Beuscher HU, Rollinghoff M, Solbach W (1991) Interferon-gamma inhibits the efficacy of interleukin 1 to generate a Th2-cell biased immune response induced by Leishmania major. Immunobiology 182:292-306